Geron Corp (GERN)
3.695
-0.04
(-0.94%)
USD |
NASDAQ |
Apr 19, 16:00
3.70
0.00 (0.00%)
After-Hours: 18:39
Geron Enterprise Value: 1.785B for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 1.785B |
| April 17, 2024 | 1.758B |
| April 16, 2024 | 1.703B |
| April 15, 2024 | 1.632B |
| April 12, 2024 | 1.736B |
| April 11, 2024 | 1.807B |
| April 10, 2024 | 1.627B |
| April 09, 2024 | 1.621B |
| April 08, 2024 | 1.567B |
| April 05, 2024 | 1.561B |
| April 04, 2024 | 1.501B |
| April 03, 2024 | 1.501B |
| April 02, 2024 | 1.441B |
| April 01, 2024 | 1.479B |
| March 28, 2024 | 1.550B |
| March 27, 2024 | 1.556B |
| March 26, 2024 | 1.550B |
| March 25, 2024 | 1.528B |
| March 22, 2024 | 1.556B |
| March 21, 2024 | 1.567B |
| March 20, 2024 | 1.627B |
| March 19, 2024 | 1.528B |
| March 18, 2024 | 1.482B |
| March 15, 2024 | 1.583B |
| March 14, 2024 | 703.85M |
| Date | Value |
|---|---|
| March 13, 2024 | 703.85M |
| March 12, 2024 | 774.84M |
| March 11, 2024 | 916.81M |
| March 08, 2024 | 976.88M |
| March 07, 2024 | 894.97M |
| March 06, 2024 | 894.97M |
| March 05, 2024 | 889.51M |
| March 04, 2024 | 884.05M |
| March 01, 2024 | 982.34M |
| February 29, 2024 | 840.36M |
| February 28, 2024 | 813.06M |
| February 27, 2024 | 875.86M |
| February 26, 2024 | 878.59M |
| February 23, 2024 | 818.52M |
| February 22, 2024 | 821.72M |
| February 21, 2024 | 799.93M |
| February 20, 2024 | 810.82M |
| February 16, 2024 | 843.52M |
| February 15, 2024 | 887.11M |
| February 14, 2024 | 892.56M |
| February 13, 2024 | 876.21M |
| February 12, 2024 | 1.040B |
| February 09, 2024 | 898.01M |
| February 08, 2024 | 789.03M |
| February 07, 2024 | 778.13M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
38.44M
Minimum
Mar 18 2020
1.807B
Maximum
Apr 11 2024
510.47M
Average
366.54M
Median
Enterprise Value Benchmarks
| Madrigal Pharmaceuticals Inc | 3.910B |
| SELLAS Life Sciences Group Inc | 81.87M |
| Johnson & Johnson | 357.61B |
| Immuneering Corp | -33.83M |
| Moderna Inc | 30.45B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -51.97M |
| Revenue (Quarterly) | 0.023M |
| Total Expenses (Quarterly) | 54.31M |
| EPS Diluted (Quarterly) | -0.09 |
| Profit Margin (Quarterly) | -226.0K% |
| Earnings Yield | -8.93% |
| Normalized Earnings Yield | -8.931 |